Risk of rosacea higher in females with migraines
Risk of rosacea higher in females with migrainesWomen who suffer from migraines may have a slightly higher risk of rosacea, a study suggests.
FDA actions in briefRecently approved drugs
FDA approves topical rosacea drugThe Food and Drug Administration has approved Galderma’s topical gel Mirvaso (brimonidine 0.33 percent) for the treatment of facial erythema from rosacea.
VIDEO: Special considerations when treating men's skinDermatologists should consider nuances of men's skin when developing treatment plans. For example, men's skin is thicker and may require additional laser passes in some areas.
Therapeutic approach for many women's skin conditions require special considerationsWomen and men are not always created equal when it comes to their dermatologic concerns, frequency and presentation of several dermatologic conditions, treatment options and outcomes.
Studies yield clues to pathology, treatment of rosaceaNew knowledge regarding rosacea’s pathology may explain why some newer treatment strategies appear effective, while pointing the way for additional approaches, according to an expert who spoke at the American Academy of Dermatology’s annual meeting.
Treating acne, rosacea in patients of color requires attention to inflammationRecent developments regarding acne and rosacea in skin of color include studies showing that combination topical products for acne appear safe in this population, and the fact that rosacea is perhaps more prevalent than many might expect.
Topical treatment options for rosacea increase
Topical treatment options for rosacea increaseThe treatment of rosacea is becoming increasingly patient-friendly, according to an expert.
Facial dermatitis may mask other conditionsThe archetypal red face of dermatitis may conceal more diagnoses than originally meet the eye, according to an expert who spoke at the annual meeting of the American Academy of Dermatology.
Knowledge of pathways key to developing new rosacea therapiesDeveloping treatments for rosacea requires first understanding the many pathways that contribute to its development, says Richard L. Gallo, M.D., Ph.D. The current hypothesis regarding the pathology of rosacea is that “there are certain triggers that we hear about from our patients, or observe ourselves,” Dr. Gallo says. “Then there’s a response,” which includes vascular, inflammatory and histopathologic changes in the skin.